ArticleThe Journal of infectious diseases2017
The Global Polio Laboratory Network as a Platform for the Viral Vaccine-Preventable and Emerging Diseases Laboratory Networks.
Article in The Journal of infectious diseases, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
24 citing papers in PubMed.
- A generalized lineage nomenclature for viral genomic epidemiology.Nature microbiology · 2026Article
- The African Polio Laboratory Network: Advancing Regional Poliovirus Detection, Genomic Surveillance, and Eradication.Vaccines · 2026Article
- Guiding principles for establishing and strengthening environmental microbiology laboratories for public health in resource-limited settings.PLOS water · 2026Article
- A review on health system-based surveillance for acute flaccid paralysis: technological advancements, challenges, and outlooks.Journal of health, population, and nutrition · 2025Review
- Article
- Advancing poliovirus eradication: lessons learned from piloting direct molecular detection of polioviruses in high-risk and priority geographies.Microbiology spectrum · 2025Article
- Harnessing laboratory data for poliovirus eradication: contributions of the Africa regional polio laboratory data management team, 2022 - 2024.Computer methods and programs in biomedicine update · 2025Article
- Surveillance To Track Progress Toward Polio Eradication - Worldwide, 2022-2023.MMWR. Morbidity and mortality weekly report · 2024Article
- Prevalence of Non-Polio Enteroviruses in the Sewage of Guangzhou City, China, from 2013 to 2021.Microbiology spectrum · 2023Article
- Surveillance To Track Progress Toward Poliomyelitis Eradication - Worldwide, 2021-2022.MMWR. Morbidity and mortality weekly report · 2023Article
- Circulating vaccine derived polio virus type 1 outbreak, Saadah governorate, Yemen, 2020.BMC infectious diseases · 2022Article
- Surveillance to Track Progress Toward Polio Eradication - Worldwide, 2020-2021.MMWR. Morbidity and mortality weekly report · 2022Article
- Culture-Independent Detection of Poliovirus in Stool Samples by Direct RNA Extraction.Microbiology spectrum · 2021Article
- Lessons from the elimination of poliomyelitis in Africa.Nature reviews. Immunology · 2021Review
- Surveillance to Track Progress Toward Polio Eradication - Worldwide, 2019-2020.MMWR. Morbidity and mortality weekly report · 2021Article
- Some lessons for malaria from the Global Polio Eradication Initiative.Malaria journal · 2021Review
- High Diversity of Human Non-Polio Enterovirus Serotypes Identified in Contaminated Water in Nigeria.Viruses · 2021Article
- Modeling and Managing Poliovirus Risks: We are Where we are….Risk analysis : an official publication of the Society for Risk Analysis · 2021Article
- Surveillance to Track Progress Toward Polio Eradication - Worldwide, 2017-2018.MMWR. Morbidity and mortality weekly report · 2019Article
- Transition Planning For After Polio Eradication.The Journal of infectious diseases · 2017Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
The Global Polio Laboratory Network (GPLN) began building in the late 1980s on a 3-tiered structure of 146 laboratories with different and complementary technical and support capacities (poliovirus isolation, molecular strain characterization including sequencing, quality assurance, and research). The purpose of this network is to provide timely and accurate laboratory results to the Global Polio Eradication Initiative. Deeply integrated with field case-based surveillance, it ultimately provides molecular epidemiological data from polioviruses used to inform programmatic and immunization activities. This network of global coverage requires substantial investments in laboratory infrastructure, equipment, supplies, reagents, quality assurance, staffing and training, often in resource-limited settings. The GPLN has not only developed country capacities, but it also serves as a model to other global laboratory networks for vaccine-preventable diseases that will endure after the polio eradication goal is achieved. Leveraging lessons learned during past 27 years, the authors discuss options for transitioning GPLN assets to support control of other viral vaccine-preventable, emerging, and reemerging diseases.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.